In-depth analysis unveils trial lawyers’ staggering advertising and political spending, exposing tactics used to shape public opinion and legal outcomes.
Gustavsen v. Alcon
(1st Circ., filed April 11, 2018): Arguing that the plaintiffs’ speculative claim that they might have paid less for a medication if defendants had packaged it more efficiently does not describe a cognizable injury in fact, and therefore, they lack standing. Accepting plaintiffs’ theory would invite abusive class-action litigation.
On August 27, 2018, the court held that defendants could not change the drop size of an FDA-approved drug without prior FDA approval and thus that plaintiffs’ state-law claims were preempted.
Explosive New Reports Uncover Shocking Trends in Legal Advertising and Campaign Contributions in New York State
ATRA’s Latest Reports Reveal the Deep Ties Between Trial Lawyers and New York Politics
This isn’t just about legal technicalities; it’s about New Yorkers’ livelihoods and ability to make ends meet.
Plaintiff-friendly courts tilt the scales of justice at will.
Report Reveals Ongoing Crisis and Urgent Need for Reform
Evolution in Legal Landscape and Emerging Challenges Highlighted